Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic. - Shurtleff VW; Layton ME; Parish CA; Perkins JJ; Schreier JD; Wang Y; Adam GC; Alvarez N; Bahmanjah S; Bahnck-Teets CM; Boyce CW; Burlein C; et al. (Journal of medicinal chemistry, 2024)